Target intelligence / Profile preview

Spinal nociceptive pathways

Molecular classification
Ion channel, G protein-coupled receptor, Neurotransmitter receptor
01

Overview

Spinal nociceptive pathways are the neural circuits within the spinal cord that process and relay pain signals from peripheral tissues to the central nervous system. These pathways begin in the dorsal horn, where primary afferent nociceptors (A-delta and C fibers) release neurotransmitters like glutamate and substance P to activate second-order neurons, including those of the spinothalamic tract [1]. This system is not a single molecular target but a complex network involving various ion channels (e.g., Cav2.2, Nav1.7) and receptors (e.g., NMDA, mu-opioid) that modulate signal intensity [2]. In pathological states, such as chronic or neuropathic pain, these pathways undergo 'central sensitization,' characterized by increased neuronal excitability and a lowered threshold for pain [3]. Therapeutic strategies targeting these pathways include the use of opioids to activate inhibitory receptors, NMDA antagonists to reduce excitability, and calcium channel blockers to inhibit neurotransmitter release [4]. Additionally, descending pathways from the brainstem provide top-down modulation, which can either inhibit or facilitate spinal nociceptive transmission [1]. Understanding these pathways is crucial for developing multi-modal analgesic strategies that address different components of the pain transmission process.

Other names
Ascending pain pathwaysSpinothalamic tractSpinal pain processing systemNociceptive transmission system
02

Mechanism of action

Modulation of synaptic transmission in the dorsal horn, inhibition of excitatory neurotransmitter release (e.g., glutamate, substance P), blockade of voltage-gated ion channels, and enhancement of descending inhibitory control [1][4].

03

Biological functions

Signal transductionSensory perceptionPain processingNociception
04

Disease associations

Chronic painNeuropathic painInflammationHyperalgesiaAllodynia
05

Safety considerations

Respiratory depressionSedationToleranceOpioid-induced hyperalgesiaAbuse potentialMotor impairment
06

Interacting drugs

Morphine

7 more in the full profile.

07

Biomarkers

Quantitative Sensory Testing (QST)Functional MRI (fMRI) of the spinal cordCerebrospinal fluid (CSF) levels of Substance PElectromyography (EMG) reflex studies

Beyond the preview

Go deeper on Spinal nociceptive pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Spinal nociceptive pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call